Adipokines Vaspin and Visfatin in Obese Children
DOI:
https://doi.org/10.3889/oamjms.2015.123Keywords:
Vaspin, visfatin, obese, children, adipokinesAbstract
BACKGROUND: Adipokines provides new insights about the physiology, pathology and treatment of obesity.
AIM: We investigated the association between serum vaspin and serum visfatin concentrations with obesity in Egyptian children.
MATERIAL AND METHODS: Twenty two obese children with body mass index (BMI) above 95th percentile; 11 males and 11 females were included in this study. Their mean age was 9.18 ± 2.8 years. After general clinical examination, fasting blood glucose, triglycerides, total cholesterol and high density lipoprotein cholesterol were measured in cases and controls (n=11). Fasting insulin, vaspin and visfatin were detected using ELIZA. Insulin resistance was estimated by Homeostasis model assessment method (HOMA-IR).
RESULTS: Blood pressure, in both systolic and diastolic measurements was elevated significantly in obese children. Significant elevation of serum insulin and insulin resistance (HOMA/IR) were observed in obese children too. Vaspin and visfatin showed significant elevation in obese children than controls. Significant positive correlations were detected between visfatin and BMI, waist circumference, hip circumference and HOMA/IR. We found that Vaspin and visfatin are higher in obese children.
CONCLUSION: Visfatin but not vaspin correlates positively with waist circumference and HOMA/IR in obese children.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Ahima RS, Osei SY. Adipokines in obesity. Front Horm Res. 2008;36:182-97.
http://dx.doi.org/10.1159/000115365 DOI: https://doi.org/10.1159/000115365
El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI. Vaspin and visfatin/Namptare interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism. 2011;60(1):63-70.
http://dx.doi.org/10.1016/j.metabol.2010.04.008 DOI: https://doi.org/10.1016/j.metabol.2010.04.008
PMid:20605615
Blüher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine. 2012;41(2):176-82.
http://dx.doi.org/10.1007/s12020-011-9572-0
PMid:22139797
Stofkovain A. Cachexia – The Interplay Between the Immune System, Brain Control and Metabolism. In: Inflammatory Diseases - Immunopathology, Clinical and Pharmacological Bases. Ed by Mahin Khatami. InTech, 2012.
http://dx.doi.org/10.5772/25436 DOI: https://doi.org/10.5772/25436
Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scand J Clin Lab Invest. 2009;69(8):858-64.
http://dx.doi.org/10.3109/00365510903348677 DOI: https://doi.org/10.3109/00365510903348677
PMid:19929281
Rabe K, Lehrke M, Parhofer KG, Broedl UC Adipokines and insulin resistance. Mol Med. 2008;14(11-12):741-51
http://dx.doi.org/10.2119/2008-00058.Rabe DOI: https://doi.org/10.2119/2008-00058.Rabe
PMid:19009016 PMCid:PMC2582855
DeClercq V, Enns JE, Yeganeh A, Taylor CG, Zahradka P. Modulation of cardiovascular function by adipokines. Cardiovasc Hematol Disord Drug Targets. 2013;13(1):59-72.
http://dx.doi.org/10.2174/1871529X11313010007 DOI: https://doi.org/10.2174/1871529X11313010007
PMid:22882074
Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G, Lampropoulos S. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta. 2011;412(1-2):48-52.
http://dx.doi.org/10.1016/j.cca.2010.09.012 DOI: https://doi.org/10.1016/j.cca.2010.09.012
PMid:20850423
Centre of disease control and prevention. Use of BMI and weight clacification especially for children shows how different children from adults. CDC Publications, 2005.
Egyptian growth curves:Diabetes endocrine metabolism pediatric unit, Cairo University Children Hospital. From http://dempuegypt.blogspot.com/. Revised 29/11/2008.
Friedwald WT, Levey RI, Frederickson DS. Estimation of the concentration of low- density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18: 499- 502. DOI: https://doi.org/10.1093/clinchem/18.6.499
Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115(4):e500-3.
http://dx.doi.org/10.1542/peds.2004-1921 DOI: https://doi.org/10.1542/peds.2004-1921
PMid:15741351
Zaki ME, Mohamed SK, Bahgat KA, Kholoussi SM. Metabolic syndrome components in obese Egyptian children. Ann Saudi Med. 2012; 32(6):603-10. DOI: https://doi.org/10.5144/0256-4947.2012.603
PMid:23396024
Raj M. Obesity and cardiovascular risk in children and adolescents. Indian J Endocrinol Metab. 2012; 16(1):13-9.
http://dx.doi.org/10.4103/2230-8210.91176 DOI: https://doi.org/10.4103/2230-8210.91176
PMid:22276248 PMCid:PMC3263181
Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, Kimball TR. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131(4):e1082-90.
http://dx.doi.org/10.1542/peds.2012-1726 DOI: https://doi.org/10.1542/peds.2012-1726
PMid:23460684 PMCid:PMC3608484
Yang F, Lv JH, Lei SF, Chen XD, Liu MY, Jian WX, Xu H, Tan LJ, Deng FY, Yang YJ, Wang YB, Sun X, Xiao SM, Jiang C, Guo YF, Guo JJ, Li YN, Zhu XZ, Papasian CJ, Deng HW. Receiver-operating characteristic analyses of body mass index, waist circumference and waist-to-hip ratio for obesity: Screening in young adults in central south of China. Clin Nutr. 2006; 25(6):1030-9.
http://dx.doi.org/10.1016/j.clnu.2006.04.009 DOI: https://doi.org/10.1016/j.clnu.2006.04.009
PMid:16884832
Cekmez F, Canpolat FE, Pirgon O, Çetinkaya M, Aydinoz S, Suleymanoglu S, Ipcioglu OM, Sarici SU. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cytokine. 2011; 56(2):387-91.
http://dx.doi.org/10.1016/j.cyto.2011.06.007 DOI: https://doi.org/10.1016/j.cyto.2011.06.007
PMid:21742512
Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H, Karabiber H, Kilinc M. Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices. Swiss Med Wkly. 2009; 139(1-2):22-7.
PMid:19142752
Taşçilar ME, Cekmez F, Meral C, Pirgon O, Tanju IA, Canpolat FE, Abaci A, Tapan S, Eker I. Evaluation of adipocytokines in obese children with insulin resistance. Turk J Pediatr. 2011; 53(3):269-73.
PMid:21980807
Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006; 91(8):3165-70.
http://dx.doi.org/10.1210/jc.2006-0361 DOI: https://doi.org/10.1210/jc.2006-0361
PMid:16720654
Breitfeld J, Tönjes A, Böttcher Y, Schleinitz D, Wiele N, Marzi C, Brockhaus C, Rathmann W, Huth C, Grallert H, Illig T, Blüher M, Kovacs P, Stumvoll M. Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond). 2012; 21:133 DOI: https://doi.org/10.1038/ijo.2012.133
Blüher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine. 2012; 41(2):176-82.
http://dx.doi.org/10.1007/s12020-011-9572-0 DOI: https://doi.org/10.1007/s12020-011-9572-0
PMid:22139797
Chang Hee Jung; Woo Je Lee; Jenie Yoonoo Hwang; Min Jung Lee; So Mi Seol; Yun Mi Kim; Yoo La Lee; Hyun Sik Kim; Min-Seon Kim; Joong-Yeol Park. Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine in Vascular Endothelial Cells. PLoS ONE. 2012;7(12):1.
http://dx.doi.org/10.1371/journal.pone.0052346 DOI: https://doi.org/10.1371/journal.pone.0052346
PMid:23284999 PMCid:PMC3532208
Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL, Park JY. Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun. 2011; 413(2):264-9.
http://dx.doi.org/10.1016/j.bbrc.2011.08.083 DOI: https://doi.org/10.1016/j.bbrc.2011.08.083
PMid:21893030
Kalker U, Hövels O, Kolbe-Saborowski H. Obese children and adolescents. Waist-hip ratio and cardiovascular risk. Monatsschr Kinderheilkd. 1993; 141(1):36-41.
PMid:8446116
Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, Asayama K, Shirahata A. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity (Silver Spring). 2008; 16(2):384-8.
http://dx.doi.org/10.1038/oby.2007.54 DOI: https://doi.org/10.1038/oby.2007.54
PMid:18239648
Sharma S, Lustig RH, Fleming SE. Identifying metabolic syndrome in African American children using fasting HOMA-IR in place of glucose. Prev Chronic Dis. 2011;8(3):A64.
PMid:21477504 PMCid:PMC3103569
Hatipoglu N, Mazicioglu MM, Poyrazoglu S, Borlu A, Horoz D, Kurtoglu S. Waist circumference percentiles among Turkish children under the age of 6 years. Eur J Pediatr. 2013;172(1):59-69
http://dx.doi.org/10.1007/s00431-012-1822-5 DOI: https://doi.org/10.1007/s00431-012-1822-5
PMid:23015041 PMCid:PMC3543614
R A, S H, Ruma D. The waist circumference measurement: a simple method for assessing the abdominal obesity. J Clin Diagn Res. 2012;6(9):1510-3.
http://dx.doi.org/10.7860/jcdr/2012/4379.2545 DOI: https://doi.org/10.7860/JCDR/2012/4379.2545
Gauvreau D, Villeneuve N, Deshaies Y, Cianflone K. [Novel adipokines: links between obesity and atherosclerosis]. Ann Endocrinol (Paris). 2011;72(3):224-31.
http://dx.doi.org/10.1016/j.ando.2010.02.025 DOI: https://doi.org/10.1016/j.ando.2010.02.025
PMid:21592454
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0